Efficacy and safety of second‐line chemotherapy for patients with advanced non‐small cell lung cancer complicated by interstitial lung disease

BACKGROUND: Treatment of non‐small cell lung cancer (NSCLC) patients with interstitial lung disease (ILD) is limited because of the risk of its acute exacerbation (AE). Furthermore, the efficacy and safety of second‐line chemotherapy for these patients is unclear. METHODS: To investigate the efficac...

Descripción completa

Detalles Bibliográficos
Autores principales: Otsuka, Kenji, Nokihara, Hiroshi, Mitsuhashi, Atsushi, Ozaki, Ryohiko, Yabuki, Yohei, Yoneda, Hiroto, Ogino, Hirokazu, Nishioka, Yasuhiko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons Australia, Ltd 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9626311/
https://www.ncbi.nlm.nih.gov/pubmed/36106507
http://dx.doi.org/10.1111/1759-7714.14645

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9626311/
https://www.ncbi.nlm.nih.gov/pubmed/36106507
http://dx.doi.org/10.1111/1759-7714.14645

Ejemplares similares